---
title: "EXCLUSIVE-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294963289.md"
datetime: "2026-08-05T12:03:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294963289.md)
  - [en](https://longbridge.com/en/news/294963289.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294963289.md)
generator: "portal-rs"
---

# EXCLUSIVE-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

By Maggie Fick and Sabrina Valle

Aug 5 (Reuters) - There are “no discussions” ongoing between AstraZeneca (AZN.L) and Bristol Myers Squibb (BMY.N) over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega merger between the drugmakers.

“There is no deal between AstraZeneca and BMS. There never was a deal to be done, and there are no discussions between the companies,” said the source, speaking on condition of anonymity.

On Sunday Reuters reported, citing a person familiar with the situation, that the two drugmakers had held preliminary talks about a possible deal that would create a pharmaceutical behemoth with a combined value of nearly $400 billion.

Reuters was unable to ascertain at that time if the discussions remained ongoing.

The Financial Times first reported news of the talks.

AstraZeneca shares slid around 9% after the reports of the deal talks, while Bristol Myers shares had held more steady.

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [AZNH.US](https://longbridge.com/en/quote/AZNH.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [AstraZeneca: SERENA-4 Trial Of Etcamah Palbociclib Combination Fails To Meet Primary Objective](https://longbridge.com/en/news/298875452.md)
- [AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears](https://longbridge.com/en/news/298828016.md)
- [BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM](https://longbridge.com/en/news/298442546.md)
- [AstraZeneca publishes transcript of ERS 2026 investor call and webcast](https://longbridge.com/en/news/298346504.md)
- [Bristol Myers Swoons on Test Results](https://longbridge.com/en/news/298335284.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**